Pakistan · Delayed Price · Currency is PKR IBL HealthCare Statistics
Total Valuation
IBL HealthCare has a market cap or net worth of PKR 4.73 billion. The enterprise value is 5.08 billion.
| Market Cap | 4.73B |
| Enterprise Value | 5.08B |
Important Dates
The last earnings date was Tuesday, April 28, 2026.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IBL HealthCare has 98.53 million shares outstanding. The number of shares has decreased by -0.36% in one year.
| Current Share Class | 98.53M |
| Shares Outstanding | 98.53M |
| Shares Change (YoY) | -0.36% |
| Shares Change (QoQ) | -0.29% |
| Owned by Insiders (%) | 1.15% |
| Owned by Institutions (%) | 6.51% |
| Float | 26.78M |
Valuation Ratios
The trailing PE ratio is 19.64.
| PE Ratio | 19.64 |
| Forward PE | n/a |
| PS Ratio | 1.06 |
| PB Ratio | 1.90 |
| P/TBV Ratio | 1.90 |
| P/FCF Ratio | 242.63 |
| P/OCF Ratio | 188.68 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.53, with an EV/FCF ratio of 260.29.
| EV / Earnings | 21.13 |
| EV / Sales | 1.13 |
| EV / EBITDA | 9.53 |
| EV / EBIT | 9.73 |
| EV / FCF | 260.29 |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.01 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 0.86 |
| Debt / FCF | 23.40 |
| Interest Coverage | 12.37 |
Financial Efficiency
Return on equity (ROE) is 10.14% and return on invested capital (ROIC) is 9.28%.
| Return on Equity (ROE) | 10.14% |
| Return on Assets (ROA) | 8.16% |
| Return on Invested Capital (ROIC) | 9.28% |
| Return on Capital Employed (ROCE) | 20.82% |
| Weighted Average Cost of Capital (WACC) | 6.55% |
| Revenue Per Employee | 20.01M |
| Profits Per Employee | 1.07M |
| Employee Count | 224 |
| Asset Turnover | 1.12 |
| Inventory Turnover | 2.60 |
Taxes
In the past 12 months, IBL HealthCare has paid 240.17 million in taxes.
| Income Tax | 240.17M |
| Effective Tax Rate | 49.98% |
Stock Price Statistics
The stock price has increased by +89.70% in the last 52 weeks. The beta is 0.45, so IBL HealthCare's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +89.70% |
| 50-Day Moving Average | 44.35 |
| 200-Day Moving Average | 53.44 |
| Relative Strength Index (RSI) | 51.84 |
| Average Volume (20 Days) | 488,290 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IBL HealthCare had revenue of PKR 4.48 billion and earned 240.39 million in profits. Earnings per share was 2.45.
| Revenue | 4.48B |
| Gross Profit | 1.70B |
| Operating Income | 521.98M |
| Pretax Income | 480.56M |
| Net Income | 240.39M |
| EBITDA | 527.32M |
| EBIT | 521.98M |
| Earnings Per Share (EPS) | 2.45 |
Balance Sheet
The company has 111.88 million in cash and 456.54 million in debt, with a net cash position of -344.66 million or -3.50 per share.
| Cash & Cash Equivalents | 111.88M |
| Total Debt | 456.54M |
| Net Cash | -344.66M |
| Net Cash Per Share | -3.50 |
| Equity (Book Value) | 2.49B |
| Book Value Per Share | 25.35 |
| Working Capital | 1.86B |
Cash Flow
In the last 12 months, operating cash flow was 25.09 million and capital expenditures -5.58 million, giving a free cash flow of 19.51 million.
| Operating Cash Flow | 25.09M |
| Capital Expenditures | -5.58M |
| Depreciation & Amortization | 5.34M |
| Net Borrowing | 61.27M |
| Free Cash Flow | 19.51M |
| FCF Per Share | 0.20 |
Margins
Gross margin is 37.94%, with operating and profit margins of 11.64% and 5.36%.
| Gross Margin | 37.94% |
| Operating Margin | 11.64% |
| Pretax Margin | 10.72% |
| Profit Margin | 5.36% |
| EBITDA Margin | 11.76% |
| EBIT Margin | 11.64% |
| FCF Margin | 0.44% |
Dividends & Yields
IBL HealthCare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.01% |
| Buyback Yield | 0.36% |
| Shareholder Yield | 0.36% |
| Earnings Yield | 5.08% |
| FCF Yield | 0.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 7, 2025. It was a forward split with a ratio of 1.15.
| Last Split Date | Oct 7, 2025 |
| Split Type | Forward |
| Split Ratio | 1.15 |
Scores
IBL HealthCare has an Altman Z-Score of 4.01 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.01 |
| Piotroski F-Score | 5 |